晚期前列腺癌双侧乳腺和腋窝淋巴结转移1例

国际肿瘤学杂志››2024,Vol. 51››Issue (7): 478-480.doi:10.3760/cma.j.cn371439-20231130-00079

• 病例报道 •上一篇

晚期前列腺癌双侧乳腺和腋窝淋巴结转移1例

刘琴, 张强强, 杨继元, 胡艳()

荆州市第一人民医院肿瘤科，荆州 434000

收稿日期:2023-11-30修回日期:2024-05-05出版日期:2024-07-08发布日期:2024-08-14
通讯作者:胡艳，Email：helensparkle@163.com
作者简介:刘琴和张强强对本文有同等贡献

Received:2023-11-30Revised:2024-05-05Online:2024-07-08Published:2024-08-14

摘要/Abstract

摘要：

前列腺癌常见转移部位有骨、远处淋巴结、肺、肝及肾上腺等，乳腺和腋窝淋巴结转移临床罕见。现回顾性分析1例前列腺癌转移至双侧乳腺和腋窝淋巴结的临床病理资料，以加强对该疾病的认识。

刘琴, 张强强, 杨继元, 胡艳. 晚期前列腺癌双侧乳腺和腋窝淋巴结转移1例[J]. 国际肿瘤学杂志, 2024, 51(7): 478-480.

图/表2

参考文献20

[1]	Albasri AM. Nasopharyngeal carcinoma metastasis to the breast[J].Saudi Med J,2020,41(10): 1130-1134. DOI:10.15537/smj.2020.10.25420. pmid:33026055
[2]	Özşen M, Tolunay S, Polatkan SAV, et al. Metastatic neoplasms to the breast[J].Int J Surg Pathol,2023: 10668969231201415. DOI:10.1177/10668969231201415.
[3]	Lee SH, Park JM, Kook SH, et al. Metastatic tumors to the breast: mammographic and ultrasonographic findings[J].J Ultrasound Med,2000,19(4): 257-262. DOI:10.7863/jum.2000.19.4.257. pmid:10759349
[4]	Wan X, Zhang HQ, Zhang YH, et al. Metastases to the breast from extramammary nonhematological malignancies: case series[J].Int J Gen Med,2020,13: 1105-1114. DOI:10.2147/ijgm.s276602. pmid:33209053
[5]	Semba R, Horimoto Y, Arakawa A, et al. Metastatic breast tumors from extramammary malignancies: a case series[J].Surg Case Rep,2021,7(1): 154. DOI:10.1186/s40792-021-01235-2. pmid:34185204
[6]	Zhou P, Chang NN, Abraham SC, et al. Metastatic nonhemato-poietic neoplasms to the breast: a study of 238 cases[J].Hum Pathol,2022,125: 59-67. DOI:10.1016/j.humpath.2022.04.009.
[7]	Hassanipour S, Delam H, Arab-Zozani M, et al. Survival rate of prostate cancer in Asian countries: a systematic review and meta-analysis[J].Ann Glob Health,2020,86(1): 2. DOI:10.5334/aogh.2607. pmid:31976303
[8]	Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis[J].Prostate,2014,74(2): 210-216. DOI:10.1002/pros.22742. pmid:24132735
[9]	Lee UJ, Jones JS. Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening[J].Prostate Cancer Prostatic Dis,2009,12(1): 52-56. DOI:10.1038/pcan.2008.26.
[10]	Lecarpentier J, Silvestri V, Kuchenbaecker KB, et al. Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores[J].J Clin Oncol,2017,35(20): 2240-2250. DOI:10.1200/jco.2016.69.4935. pmid:28448241
[11]	Karlsson CT, Malmer B, Wiklund F, et al. Breast cancer as a second primary in patients with prostate cancer—estrogen treatment or association with family history of cancer?[J].J Urol,2006,176(2): 538-543. DOI:10.1016/j.juro.2006.03.036.
[12]	Thellenberg C, Malmer B, Tavelin B, et al. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer[J].J Urol,2003,169(4): 1345-1348. DOI:10.1097/01.ju.0000056706.88960.7c. pmid:12629357
[13]	Capper CP, Rae JM, Auchus RJ. The metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer[J].Horm Cancer,2016,7(3): 149-164. DOI:10.1007/s12672-016-0259-0.
[14]	Bonacho T, Rodrigues F, Liberal J. Immunohistochemistry for diagnosis and prognosis of breast cancer: a review[J].Biotech Histochem,2020,95(2): 71-91. DOI:10.1080/10520295.2019.1651901. pmid:31502889
[15]	Lee AHS, Hodi Z, Soomro I, et al. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies[J].Histopathology,2020,77(2): 303-313. DOI:10.1111/his.14141.
[16]	Fentiman IS. The biology of male breast cancer[J].Breast,2018,38: 132-135. DOI:10.1016/j.breast.2018.01.001. pmid:29316513
[17]	Kristiansen I, Stephan C, Jung K, et al. Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, prostein, androgen receptor, ERG, NKX3.1, PSAP, and PSMA[J].Int J Mol Sci,2017,18(6): 1151. DOI:10.3390/ijms18061151.
[18]	Cheng CW, Chan LW, Ng CF, et al. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen[J].Int J Urol,2006,13(4): 463-465. DOI:10.1111/j.1442-2042.2006.01327.x.
[19]	Habacha B, Bundschuh RA, Gärtner FC, et al. Case report: breast metastasis in a prostate cancer patient[J].Nuklearmedizin,2021,60(4): 302-303. DOI:10.1055/a-1310-3633. pmid:33738785
[20]	Lima V, Martinez-Lapus FG, Demegillo KJ. Breast metastasis from castrate-resistant prostatic adenocarcinoma mimicking as a second primary: a case report[J].World J Oncol,2020,11(1): 37-40. DOI:10.14740/wjon1258. pmid:32095188

晚期前列腺癌双侧乳腺和腋窝淋巴结转移1例

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表2

参考文献20

相关文章15

编辑推荐

Metrics

本文评价

[1]	赵彪, 蒲琴, 袁美芳, 马立双, 李瀚, 杨毅, 孙朝细.基于内缘切线野的调强放疗与容积弧形调强放疗在左侧乳腺癌保乳术后放疗中的剂量学研究[J]. 国际肿瘤学杂志, 2024, 51(7): 441-447.
[2]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[3]	萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[4]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[5]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵.寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[6]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[7]	陈波光, 王苏贵, 张永杰.血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82.
[8]	赵鑫, 范学武, 田龙, 胡逸民.三维超声在前列腺癌图像引导放疗中的应用与评价研究[J]. 国际肿瘤学杂志, 2024, 51(1): 43-49.
[9]	顾花艳, 朱腾, 郭贵龙.乳房微生物群与乳腺癌：现状与未来[J]. 国际肿瘤学杂志, 2024, 51(1): 55-58.
[10]	王景, 许文婷.中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526.
[11]	冯诚天, 黄芙蓉, 曹世玉, 王健宇, 南丁阿比雅思, 姜永冬, 朱娟英.HER2阳性乳腺癌患者HER2表达水平与影像学特征的关系[J]. 国际肿瘤学杂志, 2023, 50(9): 527-531.
[12]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[13]	张露, 蒋华, 林州, 马辰莺, 徐晓婷, 王利利, 周菊英.免疫检查点抑制剂治疗复发转移性宫颈癌的疗效及预后分析[J]. 国际肿瘤学杂志, 2023, 50(8): 475-483.
[14]	王文德, 曾德.乳腺癌内分泌治疗耐药的机制研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 352-356.
[15]	李青珊, 谢鑫, 张楠, 刘帅.放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367.